Free Trial

Point72 Asset Management L.P. Buys 441,815 Shares of EverQuote, Inc. (NASDAQ:EVER)

EverQuote logo with Finance background

Point72 Asset Management L.P. raised its holdings in EverQuote, Inc. (NASDAQ:EVER - Free Report) by 2,301.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 461,013 shares of the company's stock after purchasing an additional 441,815 shares during the quarter. Point72 Asset Management L.P. owned 1.30% of EverQuote worth $9,216,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of the business. R Squared Ltd bought a new position in shares of EverQuote in the 4th quarter worth about $34,000. KLP Kapitalforvaltning AS purchased a new position in shares of EverQuote in the 4th quarter worth approximately $90,000. Asset Management One Co. Ltd. raised its holdings in shares of EverQuote by 80.4% in the 4th quarter. Asset Management One Co. Ltd. now owns 4,582 shares of the company's stock worth $90,000 after purchasing an additional 2,042 shares during the period. AlphaQuest LLC raised its holdings in shares of EverQuote by 53.9% in the 4th quarter. AlphaQuest LLC now owns 7,704 shares of the company's stock worth $154,000 after purchasing an additional 2,698 shares during the period. Finally, Tower Research Capital LLC TRC raised its holdings in EverQuote by 23.8% during the 4th quarter. Tower Research Capital LLC TRC now owns 8,968 shares of the company's stock valued at $179,000 after acquiring an additional 1,724 shares during the period. Institutional investors and hedge funds own 91.54% of the company's stock.

Analyst Ratings Changes

A number of research analysts recently commented on EVER shares. JPMorgan Chase & Co. increased their target price on EverQuote from $29.00 to $30.00 and gave the company an "overweight" rating in a research note on Tuesday, May 6th. Needham & Company LLC reissued a "buy" rating and set a $38.00 price objective on shares of EverQuote in a research report on Tuesday, May 6th. Finally, Canaccord Genuity Group dropped their price objective on shares of EverQuote from $35.00 to $30.00 and set a "buy" rating for the company in a report on Monday, February 24th. Five research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Buy" and a consensus price target of $32.50.

Get Our Latest Report on EverQuote

EverQuote Stock Down 4.4%

NASDAQ EVER traded down $1.04 on Wednesday, hitting $22.61. 548,748 shares of the stock were exchanged, compared to its average volume of 549,589. The company has a 50-day moving average price of $24.22 and a 200-day moving average price of $21.67. EverQuote, Inc. has a fifty-two week low of $16.63 and a fifty-two week high of $30.03. The company has a market cap of $807.72 million, a PE ratio of 66.50 and a beta of 0.45.

EverQuote (NASDAQ:EVER - Get Free Report) last announced its quarterly earnings results on Monday, February 24th. The company reported $0.33 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.15 by $0.18. The business had revenue of $147.46 million during the quarter, compared to the consensus estimate of $133.83 million. EverQuote had a net margin of 3.31% and a return on equity of 13.94%. As a group, equities research analysts predict that EverQuote, Inc. will post 0.72 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director David B. Blundin sold 77,600 shares of the business's stock in a transaction that occurred on Friday, March 21st. The stock was sold at an average price of $28.67, for a total transaction of $2,224,792.00. Following the completion of the transaction, the director now owns 97,920 shares in the company, valued at $2,807,366.40. The trade was a 44.21% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CTO David Brainard sold 6,609 shares of the stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $21.49, for a total transaction of $142,027.41. Following the completion of the transaction, the chief technology officer now owns 156,783 shares of the company's stock, valued at $3,369,266.67. This represents a 4.04% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 193,238 shares of company stock worth $5,264,349 over the last ninety days. 29.79% of the stock is owned by company insiders.

EverQuote Profile

(Free Report)

EverQuote, Inc operates an online marketplace for insurance shopping in the United States. The company offers auto, home and renters, and life insurance. The company serves carriers and agents, as well as indirect distributors. The company was formerly known as AdHarmonics, Inc, and changed its name to EverQuote, Inc in November 2014.

Featured Stories

Institutional Ownership by Quarter for EverQuote (NASDAQ:EVER)

Should You Invest $1,000 in EverQuote Right Now?

Before you consider EverQuote, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EverQuote wasn't on the list.

While EverQuote currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines